A 65-year-old man is evaluated for sudden-onset, excruciating pain in his right lower extr… — USMLE Step 3

A 65-year-old man is evaluated for sudden-onset, excruciating pain in his right lower extremity. He is currently on hospital day 7 following a mechanical mitral valve replacement. His daily medications include warfarin and a continuous unfractionated heparin infusion for bridging therapy until his international normalized ratio (INR) is therapeutic. His current INR is $1.6$ . Vital signs are temperature $37.1^{\circ}\text{C}$ ( $98.8^{\circ}\text{F}$ ), blood pressure $130/80 \text{ mmHg}$ , and heart rate $88/\text{min}$ . Physical examination of the right lower extremity reveals a pale, cold leg. Popliteal and dorsalis pedis pulses are absent on Doppler ultrasound. Sensation to light touch is markedly diminished over the dorsum of the foot, and the patient is unable to actively dorsiflex his right toes. Laboratory studies reveal a platelet count of $65,000/\text{mm}^3$ , a significant decrease from $280,000/\text{mm}^3$ on admission. Which of the following procedural and pharmacological interventions are indicated as the most appropriate next steps in this patient's management? (Select 3)

Immediate discontinuation of the unfractionated heparin infusionAnswer
Urgent vascular surgery consultation for surgical embolectomyAnswer
Initiation of an intravenous non-heparin anticoagulant such as argatrobanAnswer
D
Transfusion of irradiated platelets to a target of > $100,000/\text{mm}^3$ prior to surgical intervention
E
Postponement of surgical revascularization pending the results of a serotonin release assay
F
Initiation of therapeutic low-molecular-weight heparin monitored via activated partial thromboplastin time (aPTT)

Answer

The correct interventions are the immediate discontinuation of unfractionated heparin, initiation of an intravenous non-heparin anticoagulant (such as argatroban), and an urgent vascular surgery consultation for surgical embolectomy.

This patient presents with Rutherford Category IIb acute limb ischemia (rest pain, sensory loss, mild motor weakness, absent pulses), an immediately threatened limb requiring emergent surgical revascularization. The etiology is arterial thrombosis secondary to heparin-induced thrombocytopenia (HIT), evidenced by the >50% drop in platelets occurring 7 days after starting unfractionated heparin. Management requires immediately stopping all heparin products, starting a non-heparin direct thrombin inhibitor (e.g., argatroban) to prevent further thrombosis and maintain anticoagulation for his mechanical valve, and consulting vascular surgery for an emergent surgical embolectomy.

Step-by-Step Solution

Evaluate the clinical presentation of the right lower extremity.

The patient exhibits signs of Rutherford Category IIb acute limb ischemia (sensory loss, motor deficit, absent pulses).

Identifying an immediately threatened limb establishes the need for emergent surgical revascularization.

Determine the etiology of the arterial thrombosis and thrombocytopenia.

The combination of a >50% platelet drop over 7 days of heparin therapy with new-onset thrombosis strongly indicates Heparin-Induced Thrombocytopenia (HIT).

Accurate etiologic diagnosis alters the standard pharmacological approach to bridging and thrombosis management.

Formulate a comprehensive procedural and pharmacological management plan.

Discontinue all heparin, start a direct thrombin inhibitor, and proceed with emergency embolectomy.

This multimodal approach simultaneously arrests the systemic immune-mediated prothrombotic state and salvages the ischemic limb.

Key Concept

Management of acute limb ischemia in the setting of heparin-induced thrombocytopenia

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic